Evidence map›Paper›PMID 30993854›Full record

Observational studyJournal of the International AIDS Society2019

Early outcomes after implementation of treat all in Rwanda: an interrupted time series study.

Jonathan Ross, Jean d'Amour Sinayobye, Marcel Yotebieng, Donald R Hoover, Qiuhu Shi, Muhayimpundu Ribakare, Eric Remera, Marcus A Bachhuber, Gad Murenzi, Vincent Sugira and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Jonathan RossDepartment of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0001-6126-3048
Jean d'Amour SinayobyeResearch Division, Rwanda Military Hospital, Kigali, Rwanda.
Marcel YotebiengDivision of Epidemiology, College of Public Health, Ohio State University, Columbus, OH, USA.ORCID 0000-0003-2110-2631
Donald R HooverDepartment of Statistics and Biostatistics and Institute for Health, Health Care Policy and Aging Research, Rutgers the State University of New Jersey, Piscataway, NJ, USA.
Qiuhu ShiDepartment of Epidemiology and Community Health, New York Medical College, Valhalla, NY, USA.
Muhayimpundu RibakareRwanda Biomedical Center, Kigali, Rwanda.
Eric RemeraRwanda Biomedical Center, Kigali, Rwanda.
Marcus A BachhuberDepartment of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Gad MurenziResearch Division, Rwanda Military Hospital, Kigali, Rwanda.
Vincent SugiraResearch Division, Rwanda Military Hospital, Kigali, Rwanda.
Denis NashInstitute for Implementation Science in Population Health, City University of New York, New York, NY, USA.
Kathryn AnastosDepartment of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
for Central Africa IeDEA
Albert Einstein College of Medicine · USRwanda Military Hospital · RWRwanda Biomedical Center · RWCity University of New York · USNew York Medical College · USOhio Department of Health · USRutgers, The State University of New Jersey · US

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Kathryn M. Anastos · 2017 to 2026
$28.3M
Minimizing losses from HIV care under universal treatment in RwandaK23MH114752 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ROSS, JONATHAN · 2017 to 2021
$995k
NIAID NIH HHS P30 AI124414NIAID NIH HHS U01 AI096299NIMH NIH HHS K23 MH114752
6 · The paper itself

Abstract

introductionNearly all countries in sub-Saharan Africa have adopted policies to provide antiretroviral therapy (ART) to all persons living with HIV (Treat All), though HIV care outcomes of these programmes are not well-described. We estimated changes in ART initiation and retention in care following Treat All implementation in Rwanda in July 2016.

methodsWe conducted an interrupted time series analysis of adults enrolling in HIV care at ten Rwandan health centres from July 2014 to September 2017. Using segmented linear regression, we assessed changes in levels and trends of 30-day ART initiation and six-month retention in care before and after Treat All implementation. We compared modelled outcomes with counterfactual estimates calculated by extrapolating baseline trends. Modified Poisson regression models identified predictors of outcomes among patients enrolling after Treat All implementation.

resultsAmong 2885 patients, 1803 (62.5%) enrolled in care before and 1082 (37.5%) after Treat All implementation. Immediately after Treat All implementation, there was a 31.3 percentage point increase in the predicted probability of 30-day ART initiation (95% CI 15.5, 47.2), with a subsequent increase of 1.1 percentage points per month (95% CI 0.1, 2.1). At the end of the study period, 30-day ART initiation was 47.8 percentage points (95% CI 8.1, 87.8) above what would have been expected under the pre-Treat All trend. For six-month retention, neither the immediate change nor monthly trend after Treat All were statistically significant. While 30-day ART initiation and six-month retention were less likely among patients 15 to 24 versus >24 years, the predicted probability of both outcomes increased significantly for younger patients in each month after Treat All implementation.

conclusionsImplementation of Treat All in Rwanda was associated with a substantial increase in timely ART initiation without negatively impacting care retention. These early findings support Treat All as a strategy to help achieve global HIV targets.

Indexed as

AdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansInterrupted Time Series AnalysisMaleMedication AdherenceRwandaYoung AdultAnti-HIV AgentsAfricaantiretroviral therapyHIVretention in careTreat Alluniversal test and treat

Identifiers

PMID30993854
PMCPMC6468264
OpenAlexW2936128867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.